India-U.S. Trade Shakeup is an Opportunity or Risk for Key Industries
India’s trade policies are in focus as talks on lowering tariffs on U.S. imports gain momentum. Reducing tariffs could make electronics, automobiles, and medical devices more affordable, with prices dropping 10-20%, benefiting consumers and boosting demand. However, domestic industries like steel, textiles, and auto components may struggle with increased competition, impacting margins and jobs. Meanwhile, sectors like electric vehicles, semiconductors, and healthcare could gain a competitive edge with lower input costs.
A key concern is the widening U.S. trade deficit with India, which stood at $45.7 billion in 2024. While this benefits Indian exporters, it also raises the risk of U.S. trade restrictions. Key industries like IT services ($193 billion) and pharmaceuticals ($7.55 billion in U.S. exports) could be affected, impacting major players like TCS, Infosys, Wipro, Sun Pharma, and Dr. Reddy’s.
With the U.S. tightening trade policies and imposing tariffs on China, India must tread carefully. Bilateral trade reached $129.2 billion in 2024, and escalating tariffs could lead to reduced market access and restrictions on Indian exports.
To stay competitive, Indian businesses must embrace AI-driven automation, robotics, and cost optimization. Strengthening local supply chains, scaling up production, and driving innovation under "Make in India" will be key. A smart trade strategy, backed by reforms and technology-led efficiency, will ensure India remains resilient and globally competitive.